RENB Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 mai 2024 @ 22:00):

Stats
Dagens volum	242 465
Gjennomsnittsvolum	439 714
Markedsverdi	219.78M
EPS	$0 ( 2024-05-17 )
Neste inntjeningsdato	( $0 ) 2024-07-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.860
ATR14	$0.00700 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-26	Mcnicol Jayne	Buy	52 817	Option to Purchase Common Stock
2024-03-06	Sapirstein James	Buy	28 196	Option to Purchase Common Stock
2024-03-11	Tarsh Simon	Buy	10 000	Option to purchase shares of common stock
2024-03-11	Tarsh Simon	Buy	0
2023-12-27	Brosgart Carol L	Buy	23 810	Option to purchase shares of common stock

INSIDER POWER
49.79
Last 81 transactions
Buy: 42 233 846 \| Sell: 31 302 462

Volum Korrelasjon

Lang: -0.24 (neutral)

Kort: 0.53 (weak)

Signal:(53.287) Neutral

Renovaro Biosciences Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Renovaro Biosciences Inc. Korrelasjon - Valuta/Råvare

-0.26
( neutral )

-0.31
( neutral )

0.00
( neutral )

-0.12
( neutral )

-0.41
( neutral )

Financial Reports:

No articles found.

Renovaro Biosciences Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Renovaro Biosciences Inc.

Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company\'s product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.